DULCOLAX SUPPOSITORY

Страна: Канада

Язык: английский

Источник: Health Canada

Активный ингредиент:

BISACODYL

Доступна с:

BOEHRINGER INGELHEIM (CANADA) LTD LTEE

код АТС:

A06AB02

ИНН (Международная Имя):

BISACODYL

дозировка:

5MG

Фармацевтическая форма:

SUPPOSITORY

состав:

BISACODYL 5MG

Администрация маршрут:

RECTAL

Штук в упаковке:

3

Тип рецепта:

OTC

Терапевтические области:

CATHARTICS AND LAXATIVES

Обзор продуктов:

Active ingredient group (AIG) number: 0101506001; AHFS:

Статус Авторизация:

CANCELLED POST MARKET

Дата Авторизация:

2013-12-05

Характеристики продукта

_Dulcolax Prescribing Information _
PRESCRIBING INFORMATION
DULCOLAX
®
Bisacodyl
Tablets 5 mg
Suppositories 5 mg (children) and 10 mg (adult)
Boehringer Ingelheim Std.
Stimulant Laxative
Boehringer Ingelheim Canada Ltd.
5180 South Service Rd.
Burlington, ON L7L 5H4
CCDS: 0074-06
Date of Revision:
August 16, 2013
Submission Control No:
142262, 142263, 142264
_Dulcolax Prescribing Information _
TABLE OF CONTENTS
[To update, right-click anywhere in the Table of Contents and select
“Update Field”, “Update
entire table”, click OK.]
PART I: HEALTH PROFESSIONAL INFORMATION
.........................................................3
SUMMARY PRODUCT INFORMATION
........................................................................3
INDICATIONS AND CLINICAL USE
..............................................................................3
CONTRAINDICATIONS
...................................................................................................3
WARNINGS AND PRECAUTIONS
..................................................................................3
ADVERSE REACTIONS
....................................................................................................5
DRUG INTERACTIONS
....................................................................................................5
DOSAGE AND ADMINISTRATION
................................................................................6
OVERDOSAGE
..................................................................................................................6
STORAGE AND STABILITY
............................................................................................7
DOSAGE FORMS, COMPOSITION AND PACKAGING
...............................................7
PART III: CONSUMER
INFORMATION................................................................................8
_ _
_Dulcolax Prescribing Information Page 3 of 11_
DULCOLAX
®
Bisacodyl
PART I: HEALTH PROFESSIONAL INFORMATION
SUMMARY PRODUCT INFORMATION
ROUTE OF
ADMINISTRATION
DOSAGE FOR